BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -0.37% |
| Q2 2025 | 23.37% |
| Q1 2025 | 103.13% |
| Q4 2024 | -47.07% |
| Q3 2024 | -13.94% |
| Q2 2024 | -32.60% |
| Q1 2024 | -19.66% |
| Q4 2023 | -18.57% |
| Q3 2023 | 11.61% |
| Q2 2023 | 16.57% |
| Q1 2023 | -0.29% |
| Q4 2022 | 21.58% |
| Q3 2022 | -0.09% |
| Q2 2022 | -9.34% |
| Q1 2022 | 5.94% |
| Q4 2021 | 10.87% |
| Q3 2021 | 5.71% |
| Q2 2021 | 53.25% |
| Q1 2021 | 7.17% |
| Q4 2020 | 7.48% |
| Q3 2020 | 16.79% |
| Q2 2020 | -11.18% |
| Q1 2020 | -2.18% |
| Q4 2019 | 29.87% |
| Q3 2019 | 77.13% |
| Q2 2019 | 98.66% |
| Q1 2019 | 18.10% |
| Q4 2018 | 0.96% |
| Q3 2018 | -3.89% |
| Q2 2018 | -6.30% |
| Q1 2018 | 17.44% |
| Q4 2017 | 0.65% |
| Q3 2017 | -8.01% |
| Q2 2017 | 11.11% |
| Q1 2017 | -33.00% |
| Q4 2016 | -13.86% |
| Q3 2016 | -17.05% |
| Q2 2016 | 18.80% |
| Q1 2016 | 18.43% |
| Q4 2015 | 29.21% |